For instance, neurofibromin 2 (NF2, also known as Merlin), which is known to be mutationally inactivated in some cancers [32], is rarely mutated in FBC [37] and initial genetic characterization of MBC did not unveil any alteration in core Hippo pathway components [38]. This evidence concerns the gene NF2 and cancer.